卵巢组织冷冻保存后的妊娠结局:一项澳大利亚队列研究
该回顾性队列研究纳入1995年7月至2022年7月在澳大利亚维多利亚州最大卵巢组织冷冻保存中心接受该技术的593例患者,通过数据链接获取围产期与死亡数据。48例(8.1%)接受卵巢组织移植,106例(17.9%)死于原发疾病并发症,共114例女性报告192名新生儿。移植组与非移植组总体妊娠率在时间-事件分析中无显著差异(校正亚分布风险比1.378,95%CI 0.755-2.515,P=.296)。
要点
- 593例卵巢组织冷冻保存患者中,48例(8.1%)接受移植,106例(17.9%)死亡。
- 共114例女性报告192名新生儿,移植组12/48(25.0%),非移植组102/545(18.7%)。
- 多数女性在冷冻保存后15年内报告妊娠;移植组与非移植组总体妊娠率无显著差异(校正亚分布风险比1.378,95%CI 0.755-2.515,P=.296)。
核心结论
- 这项南半球大型单中心队列研究显示,每5名接受卵巢组织冷冻保存的女性中约有1名实现妊娠,强调该技术作为生育力保存选项的临床可行性,可用于未来生育咨询。
研究设计与样本
- 回顾性队列研究,纳入1995年7月至2022年7月在澳大利亚维多利亚州最大卵巢组织冷冻保存中心接受该技术的593例患者,研究时年龄超过18岁。
- 围产期与死亡数据通过数据链接从维多利亚州围产期数据收集库与出生死亡婚姻登记库获取。
主要发现
- 593例患者全部成功链接至围产期与死亡数据库,其中6例(1.0%)妊娠缺乏围产期数据,17例死亡数据未反映在链接中但由近亲报告给提供卵巢组织冷冻保存的诊所。
- 48例(8.1%)接受卵巢组织移植,106例(17.9%)死于组织冷冻所针对医学适应证的并发症。
- 移植组与非移植组共报告来自114例女性的192名新生儿:移植组12/48(25.0%),非移植组102/545(18.7%)。
- 多数女性在卵巢组织冷冻保存后15年内报告妊娠;时间-事件分析显示移植组与非移植组总体妊娠率相似(校正亚分布风险比1.378,95%置信区间0.755-2.515,P=.296)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ovarian tissue cryopreservation is an increasingly utilized fertility preservation method in young women, with this technique being largely implemented across Europe and Australia. Australia is a pioneer of ovarian tissue cryopreservation, but the clinical perinatal outcomes are currently unknown for the Australian population. These outcomes are important as they contribute to the global understanding of which patients can benefit from this fertility preservation option. OBJECTIVE: To examine the pregnancy and mortality outcomes of patients who have undergone ovarian tissue cryopreservation and/or ovarian tissue transplantation in Victoria, Australia, and investigate predictors of success. STUDY DESIGN: A retrospective cohort study was conducted including patients who underwent ovarian tissue cryopreservation from July 1995-July 2022 at the largest ovarian tissue cryopreservation center in Victoria, Australia. Patients over the age of 18 at the time of the study were included in the study. Perinatal and mortality data were obtained through data linkage from the Victorian Perinatal Data Collection and Births Deaths and Marriages databases. RESULTS: Overall, 593 patients had undergone ovarian tissue cryopreservation between July 1995 and July 2022 in Victoria, Australia. All 593 patients were successfully linked to the perinatal and mortality databases, of whom 6 (1.0%) had pregnancies lacking perinatal data, and 17 had mortality data not reflected in the linkage but next of kin reported their deaths to the ovarian tissue cryopreservation providing clinic. Of this cohort, 48 (8.1%) underwent ovarian tissue transplantation and 106 (17.9%) died from complications of their medical indication for tissue freezing. A total of 192 neonates from 114 women were reported from both transplant (n=12/48, 25.0%) and nontransplant (n=102/545, 18.7%) cohorts. Most women had reported pregnancies by 15 years after ovarian tissue cryopreservation, with transplant cases having a similar overall pregnancy rate as per the time-to-event analysis (adjusted subdistribution hazard ratio 1.378, 95% confidence interval 0.755-2.515, P=.296). CONCLUSION: This is a large single-center cohort study within the southern hemisphere that investigates patients who have undergone ovarian tissue cryopreservation, with one in 5 women achieving a pregnancy, emphasizing the clinical feasibility of ovarian tissue cryopreservation as a fertility preservation option for future fertility counseling.
引用
- Finkelstein T, Rolnik DL, Agresta F, et al. Pregnancy outcomes following ovarian tissue cryopreservation: an Australian cohort study. Am J Obstet Gynecol. 2025. PMID: 39923876. doi:10.1016/j.ajog.2025.02.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。